We postulate that the age difference at epilepsy onset between patients with FCDs and neuroglial tumours can be attributed – at least partially – to unidentified genetic factors underlying the epileptogenic potential of the brain tissue. Additionally, the large variance in the age at epilepsy onset is possibly also genetically determined.